Porton Down Science Park
Wiltshire
SP4 0JQ
GW is developing a portfolio of cannabinoid medicines, of which the lead product is Sativex, an oromucosal spray for the treatment of MS symptoms, cancer pain and neuropathic pain.
| Description | Report Date | Published |
|---|---|---|
| Annual Report 2013 | 30-09-2013 | 06-12-2013 |
| Annual Report 2012 | 30-06-2012 | 27-11-2012 |
| Annual Report 2011 | 30-09-2011 | 21-11-2011 |
| Annual Report 2010 | 30-09-2010 | 22-11-2010 |
| Description | Report Date | Published |
|---|---|---|
| Interim Report 2014 | 31-03-2014 | 07-05-2014 |
| Interim Report 2013 | 31-03-2013 | 14-05-2013 |
| Interim Report 2012 | 31-03-2012 | 22-05-2012 |
| Interim Report 2011 | 31-03-2011 | 17-05-2011 |
| Description |
|---|
| Site Map |
| Presentations |
| Home |
| Results Index |
| Press Releases |
| Contacts |
| Type | Dividend | Payment Date |
|---|---|---|
| Nil | 0.0000 | 01-01-1970 |